KALA BIO set November 3, 2026, for its next annual meeting and September 19, 2026, as the deadline for Shareholder proposals and meeting notices. The deadline matters to investors because proposals, director nominations and other Business must meet applicable proxy, bylaw and legal requirements to be considered.
Key Highlights
- KALA BIO will provide the annual meeting’s exact time, location and voting matters in its proxy statement.
- Delivery of shareholder materials is required at 1167 Massachusetts Avenue, Arlington, Massachusetts 02476.
- Proposals may be omitted if they Fail the company’s bylaws or applicable Securities and Exchange Commission requirements.
KALA BIO, Inc. (NASDAQ: KALA) set November 3, 2026, for its next annual meeting of stockholders. The company also set September 19, 2026, as the deadline for stockholder proposals seeking inclusion in its proxy materials under Rule 14a-8. Investors seeking to nominate directors or present other business must meet that same deadline under KALA BIO’s bylaws.
September 19 Deadline Covers Proposals and Nominations
The Board established the meeting date on September 9, 2026, while the company plans to provide the exact time, location and matters for shareholder voting in its proxy statement. Proposals must comply with KALA BIO’s Third Amended and Restated By-Laws and applicable Securities and Exchange Commission requirements. Materials that fail those requirements may be omitted from the proxy materials. Notices for director nominations or other matters governed by the bylaws must also be delivered to the Secretary by September 19, 2026, at 1167 Massachusetts Avenue, Arlington, Massachusetts 02476.
FAQs
Q: When is KALA BIO’s 2026 annual meeting?
A: KALA BIO’s next annual meeting is set for November 3, 2026. The proxy statement will provide the meeting’s exact time, location and voting matters.
Q: What is the KALA BIO shareholder proposal deadline?
A: Stockholder proposals under Rule 14a-8 must reach KALA BIO’s Secretary by September 19, 2026. Proposals must also comply with applicable company bylaws and Securities and Exchange Commission requirements.
Q: How can KALA BIO investors nominate a director?
A: Investors must submit timely notice to KALA BIO’s Secretary by September 19, 2026. Director nominations must follow the company’s bylaws and other applicable legal requirements.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.